Converge Supply Chain Series event on 2/13/20

Current Trends & Challenges in Commercial Supply Chain Launch Preparation

Life Sciences Image Collage

In preparing for commercial launch, emerging life science companies face unique obstacles due to clinical, regulatory, operational and market uncertainties that can cause delays or inhibit success of the launch altogether. Current business strategies and patient outcomes-focused models place added demands and constraints on the commercial supply chain.

Join Supply Chain, Manufacturing, CMC, QA, Finance, and IT peers along with Converge Consulting to discuss industry trends and lessons learned from recent examples of building commercial supply chains for launch. This includes proven tips for success as your organization commercializes drug candidates and looks toward becoming a multiproduct global business.

Trends we are seeing include:

  • Planning for multiple launches in rapid succession 
  • Building a high-touch specialty supply chain for orphan and rare diseases 
  • Launch planning and preparation for combination products 
  • Operating with virtual and/or ultra-lean organizations 

Challenges up for discussion:

  • CMO management and governance 
  • Building risk management into launch processes 
  • Gating strategies for hiring and investment 
  • Direct-to-hospital and direct-to-patient strategies

Event Details

Date: Thursday, February 13, 2020
Venue: Boston Marriott Cambridge, 50 Broadway, Cambridge, MA

5:00p – Food, cocktails & networking
6:00p – Roundtable/presentation & discussion
7:30p – Networking


Headshot of Vin Kosewski

Vin Kosewski, SVP of Manufacturing & Supply Chain Management at Kala Pharmaceuticals, Inc.

Vin Kosewski has served as SVP of Manufacturing & Supply Chain Management since July 2017. Prior to Kala, Kosewski served as VP, Supply Chain Operations at Sunovion Pharmaceuticals Inc., VP & GM at Sunovion’s manufacturing subsidiary, Sepracor Canada Ltd., and held several positions at Sepracor, Inc., including VP, Supply Chain Operations. He began his pharmaceutical career at Astra USA, Inc. with positions in quality assurance, manufacturing, procurement, and business development. Kosewski holds a BS in Chemistry from Fairfield University and an MBA from Bryant University.

Headshot of Todd Applebaum

Todd Applebaum, Managing Director at Converge Consulting LLC

Todd Applebaum has supported many clients transitioning from clinical development to commercial production of Biologics, Pharmaceuticals, and Cell Therapies, as well as consulted business strategy, manufacturing, technical operations, the quality system, process development, operational strategy and execution, supply chain management, business process/workflow automation and IT enterprise solutions. Prior to starting Converge Consulting, Applebaum served as VP, Technical Operations at Ovascience, Inc., helping transition the company from research to commercial operations, and as VP, Research for the Healthcare and Life Science industries at Gartner, Inc. where his research focused on building patient outcomes-focused operations, impacts of personalized and precision medicines, global operations and network planning, track & trace technologies and operational & performance excellence. He holds a BS in Industrial Engineering from General Motors Institute and an MBA from Carnegie Mellon University.

This is an open forum to discuss commercial launch preparation and supply chain practices.

Please share this invitation with your colleagues and team leads.

We look forward to seeing you in February.